Detalhe da pesquisa
1.
Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
Int J Obes (Lond)
; 34(1): 118-26, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19823188
2.
Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.
J Mol Med (Berl)
; 86(10): 1153-61, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18600307
3.
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study.
Arterioscler Thromb Vasc Biol
; 27(10): 2250-7, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17656673
4.
Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.
J Clin Invest
; 91(5): 2185-93, 1993 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-8387542
5.
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.
J Thromb Haemost
; 5(3): 475-82, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17204132
6.
Chronic plasminogen activator inhibitor-1 (PAI-1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung.
J Thromb Haemost
; 5(12): 2467-75, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17848179
7.
Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Circulation
; 111(18): 2299-305, 2005 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15867179
8.
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.
Circulation
; 109(11): 1343-8, 2004 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-15023872
9.
In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabetics.
Diabetes
; 36(9): 991-5, 1987 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-3038641
10.
Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.
Diabetes
; 46(5): 860-7, 1997 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-9133556
11.
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
Diabetes
; 49(8): 1374-80, 2000 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-10923640
12.
Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue.
Diabetes
; 48(4): 890-5, 1999 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10102708
13.
On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice.
J Thromb Haemost
; 3(6): 1174-9, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15946208
14.
TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study.
J Thromb Haemost
; 3(7): 1503-10, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15978108
15.
Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study.
Atherosclerosis
; 179(2): 317-23, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15777548
16.
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro.
Atherosclerosis
; 183(2): 283-92, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15921688
17.
Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors.
Arterioscler Thromb Vasc Biol
; 20(9): 2156-61, 2000 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-10978263
18.
Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study.
Arterioscler Thromb Vasc Biol
; 21(3): 407-14, 2001 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11231921
19.
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
Arterioscler Thromb Vasc Biol
; 22(5): 867-73, 2002 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12006404
20.
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.
Diabetes Care
; 21(11): 1967-72, 1998 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-9802752